AR015190A1 - Un polimorfo cristalino de 1,3-diciclopropilmetil-8-aminoxantina, procedimiento para su preparacion, composiciones farmaceuticas que lo contienen y su usopara la manufactura de un medicamento - Google Patents

Un polimorfo cristalino de 1,3-diciclopropilmetil-8-aminoxantina, procedimiento para su preparacion, composiciones farmaceuticas que lo contienen y su usopara la manufactura de un medicamento

Info

Publication number
AR015190A1
AR015190A1 ARP980105252A ARP980105252A AR015190A1 AR 015190 A1 AR015190 A1 AR 015190A1 AR P980105252 A ARP980105252 A AR P980105252A AR P980105252 A ARP980105252 A AR P980105252A AR 015190 A1 AR015190 A1 AR 015190A1
Authority
AR
Argentina
Prior art keywords
manufacture
preparation
pharmaceutical compositions
crystalline polymorph
diciclopropilmetil
Prior art date
Application number
ARP980105252A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR015190A1 publication Critical patent/AR015190A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un polimorfo cristalino de 1,3-diciclopropilmetil-8-aminoxantina, que exhibe un modelo de difraccion de rayos X a través de polvo que tiene picoscaracterísticos expresados en distancias interplanares d (A), en intensidad decreciente, a aproximadamente 12,302, 7,702, 8,532, 4,289 y 2,854, y como seexpresa en la figura 1, procedimientos para su preparacion, composiciones farmacéuticas de las mismas, y su uso para la manufactura de un medicamento.
ARP980105252A 1997-10-23 1998-10-21 Un polimorfo cristalino de 1,3-diciclopropilmetil-8-aminoxantina, procedimiento para su preparacion, composiciones farmaceuticas que lo contienen y su usopara la manufactura de un medicamento AR015190A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6323897P 1997-10-23 1997-10-23

Publications (1)

Publication Number Publication Date
AR015190A1 true AR015190A1 (es) 2001-04-18

Family

ID=22047900

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105252A AR015190A1 (es) 1997-10-23 1998-10-21 Un polimorfo cristalino de 1,3-diciclopropilmetil-8-aminoxantina, procedimiento para su preparacion, composiciones farmaceuticas que lo contienen y su usopara la manufactura de un medicamento

Country Status (28)

Country Link
US (2) US6583283B1 (es)
EP (1) EP1025103A4 (es)
JP (1) JP2001520228A (es)
KR (1) KR20010031246A (es)
CN (1) CN1280579A (es)
AP (1) AP2000001793A0 (es)
AR (1) AR015190A1 (es)
AU (1) AU751561B2 (es)
BG (1) BG104368A (es)
BR (1) BR9814099A (es)
CA (1) CA2306980A1 (es)
CO (1) CO4990930A1 (es)
DZ (1) DZ2629A1 (es)
EA (1) EA003445B1 (es)
HU (1) HUP0100019A3 (es)
ID (1) ID23885A (es)
IL (1) IL135711A0 (es)
MA (1) MA24682A1 (es)
NO (1) NO20002012L (es)
NZ (1) NZ504051A (es)
PE (1) PE122599A1 (es)
PL (1) PL340257A1 (es)
SA (1) SA99191117A (es)
SK (1) SK5642000A3 (es)
TR (1) TR200001109T2 (es)
UY (2) UY25220A1 (es)
WO (1) WO1999020625A1 (es)
ZA (1) ZA989622B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200300622A1 (ru) 2001-01-31 2003-12-25 Пфайзер Продактс Инк. Производные амидов тиазолил-, оксазолил, пирролил- и имидазолилкислот, полезные в качестве ингибиторов изоферментов pde4
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
OA12541A (en) 2001-01-31 2006-06-05 Pfizer Prod Inc Ether derivatives useful as inhibitors of PDE4 isozymes.
NZ526453A (en) 2001-01-31 2005-01-28 Pfizer Prod Inc Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
DE60319980T2 (de) 2002-05-31 2009-04-16 Schering Corporation Xanthin-phosphodiesterase-v-hemmer polymorphe
CN101031293A (zh) 2004-05-06 2007-09-05 普莱希科公司 Pde4b抑制剂及其应用
CN101048407A (zh) 2004-09-03 2007-10-03 普莱希科公司 双环杂芳基pde4b抑制剂
JP5119153B2 (ja) * 2005-09-20 2013-01-16 シノファーム シンガポール ピーティーイー，リミテッド イリノテカン塩酸塩の新規結晶形

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906792D0 (en) 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
GB9020959D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds
GB9020921D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
PL340257A1 (en) 2001-01-29
SA99191117A (ar) 2005-12-03
MA24682A1 (fr) 1999-07-01
ID23885A (id) 2000-05-25
DZ2629A1 (fr) 2003-03-08
AP2000001793A0 (en) 2000-06-30
IL135711A0 (en) 2001-05-20
EP1025103A1 (en) 2000-08-09
UY25220A1 (es) 2001-08-27
AU751561B2 (en) 2002-08-22
NO20002012D0 (no) 2000-04-17
EA003445B1 (ru) 2003-06-26
BG104368A (en) 2001-02-28
CN1280579A (zh) 2001-01-17
PE122599A1 (es) 2000-02-12
TR200001109T2 (tr) 2000-09-21
ZA989622B (en) 1999-04-23
EP1025103A4 (en) 2001-11-14
UY25380A1 (es) 1999-11-17
EA200000448A1 (ru) 2000-10-30
SK5642000A3 (en) 2000-09-12
NZ504051A (en) 2003-02-28
US6583283B1 (en) 2003-06-24
HUP0100019A3 (en) 2003-01-28
JP2001520228A (ja) 2001-10-30
CO4990930A1 (es) 2000-12-26
HUP0100019A2 (hu) 2002-01-28
WO1999020625A1 (en) 1999-04-29
US20020173648A1 (en) 2002-11-21
NO20002012L (no) 2000-04-17
CA2306980A1 (en) 1999-04-29
KR20010031246A (ko) 2001-04-16
BR9814099A (pt) 2000-10-10
AU1274499A (en) 1999-05-10

Similar Documents

Publication Publication Date Title
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
ATE188471T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
AR008462A1 (es) COMPOSICIoN FARMACÉUTICA QUE COMPRENDE OLANZAPINA Y CLORHIDRATO DE FLUOXETINA Y USO DE DICHA COMPOSICIoN PARA LA FABRICACIoN DE UN MEDICAMENTO.
EE9600019A (et) 2,8-diasendatud kinasolinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
AR008586A1 (es) Compuesto derivado de aril alquilamina alfa, alfa-disustituido, composicion farmaceutica que lo contiene, metodo para la determinacion de la actividad calcilitica de un compuesto y uso de dichos compuestos para la fabricacion de un medicamento
SE9704546D0 (sv) Novel compounds
MX9201141A (es) Ciclosporinas cristalinas, procedimiento para su produccion y composicion farmaceutica que las contiene.
EE9700043A (et) Asendatud oksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
ITMI942025A0 (it) Composizioni farmaceutiche contenenti microorganismi ingegnerizzati e loro uso per terapia
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
EE9700019A (et) 2-okso- ja 2-tio1,2-dihüdrokinolinüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
DE3680578D1 (de) Dipeptid-derivate, verfahren zur herstellung, pharmazeutische zusammensetzungen und ihre anwendung.
AR012125A1 (es) UNA SAL DE UN COMPUESTO DERIVADO DEL ÁCIDO NAFTIRIDINA CARBOXíLICO , SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO , PROCEDIMIENTO PARA PREPARARLA Y UNA COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE
HUP0102921A3 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
IL148870A (en) 2'-substituted 1,1'-biphenyl - 2 - carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
EE9600018A (et) 2,9-diasendatud puriin-6-oonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
ZA9557B (en) Optionally substituted phenylimidazolidines their preparation process and intermediates their use as medicaments and the pharmaceutical compositions containing them
HUP9901485A3 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
HUP9802393A3 (en) Benzothiazolone derivatives, their use, pharmaceutical compositions containing them, process for the preparation thereof and intermediates
AR015190A1 (es) Un polimorfo cristalino de 1,3-diciclopropilmetil-8-aminoxantina, procedimiento para su preparacion, composiciones farmaceuticas que lo contienen y su usopara la manufactura de un medicamento
HU9800512D0 (en) Salts of bismuthum and antibiotica of the moenomycin group, process for producing them, their use and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FA Abandonment or withdrawal